PROTAC IRAK4 degrader-6 is primarily used in biomedical research to target and degrade IRAK4 (Interleukin-1 Receptor-Associated Kinase 4), a protein involved in inflammatory signaling pathways. Its application is significant in studying diseases where IRAK4 plays a critical role, such as autoimmune disorders, chronic inflammation, and certain cancers. By selectively degrading IRAK4, this compound helps researchers understand the protein's function and its potential as a therapeutic target. It is also utilized in the development of novel treatments aimed at modulating immune responses and reducing inflammation in pathological conditions.